Selin Sinem Erciyas of Gün + Partners explores the growing alignment between Turkish courts and the Unified Patent Court in ...
News of two pharma deals involving Novo Nordisk and GSK and a loss for Open AI were also among the top talking points ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback